BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 109 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $177 | -46.7% | 25 | -50.0% | 0.00% | – |
Q2 2023 | $332 | +104.9% | 50 | +92.3% | 0.00% | – |
Q1 2023 | $162 | +362.9% | 26 | -99.5% | 0.00% | -100.0% |
Q4 2022 | $35 | -99.9% | 5,543 | -3.6% | 0.00% | 0.0% |
Q3 2022 | $36,000 | 0.0% | 5,751 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $36,000 | -2.7% | 5,751 | -1.3% | 0.00% | – |
Q1 2022 | $37,000 | +3600.0% | 5,829 | +7373.1% | 0.00% | – |
Q4 2021 | $1,000 | -85.7% | 78 | -85.5% | 0.00% | – |
Q3 2021 | $7,000 | -95.0% | 538 | -93.9% | 0.00% | -100.0% |
Q2 2021 | $140,000 | +122.2% | 8,822 | +44.6% | 0.00% | +200.0% |
Q1 2021 | $63,000 | +14.5% | 6,099 | -16.4% | 0.00% | -50.0% |
Q4 2020 | $55,000 | +685.7% | 7,295 | +231.6% | 0.00% | – |
Q3 2020 | $7,000 | – | 2,200 | – | 0.00% | – |
Q2 2020 | $0 | – | 0 | – | 0.00% | – |
Q1 2020 | $0 | – | 0 | – | 0.00% | – |
Q4 2019 | $0 | – | 0 | – | 0.00% | – |
Q3 2019 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
Q3 2017 | $5,000 | -16.7% | 1,000 | 0.0% | 0.00% | – |
Q2 2017 | $6,000 | -25.0% | 1,000 | 0.0% | 0.00% | – |
Q1 2017 | $8,000 | +33.3% | 1,000 | 0.0% | 0.00% | – |
Q4 2016 | $6,000 | +50.0% | 1,000 | 0.0% | 0.00% | – |
Q3 2016 | $4,000 | +33.3% | 1,000 | 0.0% | 0.00% | – |
Q2 2016 | $3,000 | -70.0% | 1,000 | 0.0% | 0.00% | -100.0% |
Q4 2015 | $10,000 | – | 1,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VHCP Management II, LLC | 6,071,142 | $50,998,000 | 20.86% |
RTW INVESTMENTS, LP | 3,458,120 | $29,048,000 | 7.65% |
ISZO CAPITAL MANAGEMENT LP | 307,366 | $2,582,000 | 4.49% |
DAFNA Capital Management LLC | 541,128 | $4,545,000 | 3.84% |
RA Capital Management | 3,489,795 | $29,314,000 | 3.60% |
EMORY UNIVERSITY | 375,348 | $3,153,000 | 2.98% |
Ghost Tree Capital, LLC | 1,500,000 | $12,600,000 | 2.35% |
ACUTA CAPITAL PARTNERS, LLC | 920,310 | $7,731,000 | 1.83% |
Avoro Capital Advisors LLC | 1,603,001 | $13,465,000 | 1.72% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,085,236 | $25,916,000 | 1.00% |